INSIDE INFORMATION: Bioretec updates its product pipeline to accelerate commercialization strategy following the first RemeOs™ FDA market authorization, and consequently updates financial targets

Posted on by

Bioretec Ltd Inside information 24 April 2023 at 1.15 p.m. EEST TAMPERE, Finland, April 24, 2023 /PRNewswire/ — Bioretec Ltd, a pioneer in bioabsorbable orthopedic implants, announced on 30 March 2023 that it had received U.S. market authorization for its RemeOs™ trauma screw from the…